CLIMB BIO, INC. Active Patents
2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2021-03-22: Application 17208163; Invention COMPOSITIONS THAT PREFERENTIALLY POTENTIATE SUBTYPES OF GABAA RECEPTORS AND METHODS OF USE THEREOF; Applicant Eliem Therapeutics, Inc.; Status Patented Case.
- 2020-12-09: Application 17116414; Invention N-ACYLETHANOLAMIDE DERIVATIVES AND USES THEREOF; Applicant ELIEM THERAPEUTICS, INC.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-22 | 17208163 | COMPOSITIONS THAT PREFERENTIALLY POTENTIATE SUBTYPES OF GABAA RECEPTORS AND METHODS OF USE THEREOF | Eliem Therapeutics, Inc. | Patented Case | 2023-02-07 | 11571432 | US20210205332A1 | Andrew D. Levin Neil Buckley | United States United States | HUI, SAN MING R |
| 2020-12-09 | 17116414 | N-ACYLETHANOLAMIDE DERIVATIVES AND USES THEREOF | ELIEM THERAPEUTICS, INC. | Patented Case | 2023-01-10 | 11547681 | US20210093589A1 | Andrew D. Levin | United States | SHAMEEM, GOLAM M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |